Sphera Funds Management’s Acorda Therapeutics ACOR Stock Holding History

Sphera Funds Management’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-417	Closed	-$1.07M	–	152
2017 Q4	$1.07M	Buy	+417	New	+$1.19M	0.13%	111
2016 Q4	–	Sell	-1,233	Closed	-$3.09M	–	123
2016 Q3	$3.09M	Buy	1,233 +416	+51%	+$1.24M	0.5%	52
2016 Q2	$2.5M	Buy	817 +209	+34%	+$680K	0.65%	47
2016 Q1	$1.93M	Sell	608 -584	-49%	-$2.42M	0.42%	52
2015 Q4	$6.12M	Sell	1,192 -1,058	-47%	-$4.62M	0.9%	15
2015 Q3	$7.16M	Buy	2,250 +1,000	+80%	+$3.88M	0.91%	23
2015 Q2	$5M	Buy	+1,250	New	+$4.83M	0.49%	44
2015 Q1	–	Sell	-659	Closed	-$3.23M	–	171
2014 Q4	$3.23M	Sell	659 -1,000	-60%	-$4.29M	0.55%	58
2014 Q3	$6.75M	Buy	1,659 +409	+33%	+$1.53M	0.83%	32
2014 Q2	$5.06M	Buy	+1,250	New	+$5.1M	1.25%	19

Other funds holding ACOR

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Sphera Funds Management's ACOR Position: Q1 2018 in Review

Sphera Funds Management sold out of Acorda Therapeutics (ACOR) in Q1 2018, closing a stake of 417 shares — an estimated $1.07M sold.

Sphera Funds Management first reported a position in ACOR in Q2 2014 and held it in 10 quarters. The position peaked at $7.16M in Q3 2015. 162 funds tracked by Wall St. Rank hold ACOR as of Q1 2018.

Sphera Funds Management reported no remaining Acorda Therapeutics position as of Q1 2018 after selling out during the quarter.
Sphera Funds Management sold 417 Acorda Therapeutics shares in Q1 2018, an estimated $1.07M.
Sphera Funds Management first reported a position in Acorda Therapeutics in Q2 2014 and held it in 10 quarters.
Sphera Funds Management's Acorda Therapeutics position peaked at $7.16M in Q3 2015.
162 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2018.

Based on Sphera Funds Management's 13F filing for Q1 2018, filed 10 May 2018.